Project Grant HT94252510678
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$234K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Wauwatosa, WI 53226, USA
Similar Awards
The Medical College of Wisconsin, Inc. (MCW) was awarded a $1,046,468 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate chemotherapy dosing in obese patients, with the goal of optimally balancing risks and benefits to avoid overtreatment and undertreatment. The research will be conducted at MCW's facilities in Milwaukee, WI and is expected to be completed by...
The Medical College of Wisconsin, Inc. was awarded a $935,999 Project Grant from the Defense Health Agency on April 15, 2023 to complete work by April 14, 2027. The grant is part of the agency's Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions for battlefield medicine and other priorities. Specifically, this award will fund research into...
The Defense Health Agency has awarded a $862,751 Project Grant to the University of Wisconsin-Milwaukee (UWM) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective June 1, 2024 through May 31, 2027, will fund a research project to study the "Impact of Recent Childbirth on Breast Cancer Prognosis and Tumor Molecular Phenotypes Among Young Black and White Women." This grant supports UWM's ongoing biomedical research initiatives focused on...
The University of Wisconsin System was awarded a $777,500 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective June 1, 2025 through May 31, 2028, will support a multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $487,217.00 to The Medical College of Wisconsin, Inc. to evaluate the safety of cervical arthroplasty for Navy and Marine Corps tactical jet aircrew. The award period runs from September 30, 2024 to September 29, 2027. The Medical College of Wisconsin, Inc. is a private, non-profit medical school and research institution in Milwaukee,...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The University of Wisconsin System was awarded a $729,778 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a 3-year research project titled "Multiomic Analysis of Liquid Biopsies for Biomarker Discovery and Therapeutic Targeting". The research aims to advance biomedical capabilities for the military and public by leveraging innovative multiomic analysis of liquid biopsies to identify novel...
The University of Wisconsin System was awarded a $1,074,650 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from September 1, 2025 to August 31, 2029, will fund research to investigate the immunomodulatory effects of chemokine signaling in renal cell carcinoma. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by addressing...
The federal Project Grant award of $210,292 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma", a project focused on advancing imaging techniques to better understand metabolic changes in brain cancer. The award was granted to The Washington University, a private research institution,...